Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Robot-Assisted Versus Manual Puncture for Pulmonary Nodule Ablation

15. juli 2026 opdateret af: Jianxing He, The First Affiliated Hospital of Guangzhou Medical University

Comparison of Robot-Assisted Versus Manual Puncture for Ablation of Pulmonary Nodules: A Prospective Cohort Study

Pulmonary nodule ablation is an established minimally invasive treatment for selected patients with pulmonary nodules. Accurate puncture is critical for procedural efficiency and safety. This prospective observational cohort study aims to compare robot-assisted and conventional manual CT-guided puncture techniques for pulmonary nodule ablation. The primary outcomes are the number of intraoperative CT scans and needle adjustments. Secondary outcomes include puncture success, puncture accuracy, radiation exposure, and procedure-related complications. The results will provide evidence regarding the clinical effectiveness and safety of robot-assisted puncture in pulmonary nodule ablation.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

Pulmonary nodule ablation has become an important minimally invasive treatment option for patients who are unsuitable for surgical resection or who prefer image-guided local therapy. Successful CT-guided ablation depends on accurate needle placement, which may require repeated CT scans and multiple needle adjustments when conventional manual puncture is used. Robotic navigation systems have the potential to improve puncture precision and procedural efficiency while maintaining procedural safety.

This prospective observational cohort study compares robot-assisted puncture using the TH-S1 robotic navigation system with conventional manual CT-guided puncture in patients undergoing pulmonary nodule ablation. Participants are assigned to treatment groups according to routine clinical practice without randomization.

The primary outcomes are the number of intraoperative CT scans and needle adjustments. Secondary outcomes include puncture success, puncture deviation distance, radiation exposure measured by dose-length product (DLP), and procedure-related complications. Baseline characteristics will be adjusted using propensity score-based weighting methods before comparative analyses.

The study aims to evaluate whether robot-assisted puncture improves procedural efficiency while maintaining comparable safety and technical success relative to conventional manual puncture.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

104

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Guangdong
      • Guangzhou, Guangdong, Kina
        • The First Affiliated Hospital of Guangzhou Medical University

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

Adult patients with peripheral pulmonary nodules who underwent CT-guided thermal ablation at the First Affiliated Hospital of Guangzhou Medical University. Participants received either robot-assisted or conventional manual puncture according to routine clinical practice.

Beskrivelse

Inclusion Criteria:

  • Age ≥18 years.
  • Patients with peripheral pulmonary nodules scheduled for CT-guided thermal ablation.
  • Eligible for either robot-assisted or conventional manual puncture according to routine clinical practice.
  • Written informed consent provided.

Exclusion Criteria:

  • Pulmonary nodules unsuitable for percutaneous ablation because of proximity to major vessels, bronchi, or other critical structures.
  • Previous thoracic surgery or local treatment affecting puncture planning.
  • Severe cardiopulmonary dysfunction or other contraindications to CT-guided ablation.
  • Pregnancy.
  • Inability or unwillingness to provide informed consent.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Robot-Assisted Puncture
Patients undergoing CT-guided pulmonary nodule ablation using the TH-S1 robotic navigation system.
Manual Puncture
Patients undergoing conventional manual CT-guided pulmonary nodule ablation.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Number of Needle Adjustments
Tidsramme: During the procedure
Total number of needle adjustments required to achieve the planned puncture trajectory.
During the procedure
Number of Intraoperative CT Scans
Tidsramme: During the procedure
Total number of CT scans performed during the puncture procedure.
During the procedure

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Technical Success Rate
Tidsramme: During the procedure
Technical success was defined as successful completion of the planned CT-guided puncture and ablation procedure.
During the procedure
Puncture Deviation
Tidsramme: During the procedure
Puncture deviation was measured as the distance (mm) between the planned target point and the actual needle tip position after puncture.
During the procedure
Radiation Exposure
Tidsramme: During the procedure
Radiation exposure was assessed using the cumulative dose-length product (DLP, mGy·cm) recorded during the procedure.
During the procedure
Procedure-Related Complications
Tidsramme: Within 48 hours after the procedure
Procedure-related complications were evaluated and graded according to the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) classification system.
Within 48 hours after the procedure

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

12. december 2024

Primær færdiggørelse (Faktiske)

24. juni 2025

Studieafslutning (Faktiske)

26. juni 2025

Datoer for studieregistrering

Først indsendt

15. juli 2026

Først indsendt, der opfyldte QC-kriterier

15. juli 2026

Først opslået (Faktiske)

20. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

20. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

15. juli 2026

Sidst verificeret

1. juli 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner